Robbing Ebola To Pay For Zika: Playing With Fire?
This article was originally published in Scrip
Executive Summary
Since early this year, the Obama administration has been shifting money around to cover the costs of the work being done by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), the FDA and other federal agencies to address the Zika crisis in the Americas and to prepare the US for the invasion of the virus.
You may also be interested in...
NIH's Zika Vaccine Faces Funding Challenge After Skipping Industry Partnership
Agency wanted to move fast, but is now scrambling to pay for Phases I and II trials.
Playing the Long Game, Partnerships Required For Emerging Infectious Diseases
Bringing drugs and vaccines for emerging infectious diseases to the marketplace requires playing the long game and collaborations if efforts are going to be successful.
Moderna's Valera Takes mRNA Approach To Combat Zika
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.